Vascular Solutions (Nasdaq: VASC) is expected to report Q2 earnings on July 23. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Vascular Solutions's revenues will grow 9.1% and EPS will grow 13.3%.

The average estimate for revenue is $27.0 million. On the bottom line, the average EPS estimate is $0.17.

Revenue details
Last quarter, Vascular Solutions reported revenue of $26.1 million. GAAP reported sales were 8.2% higher than the prior-year quarter's $23.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.16. GAAP EPS of $0.13 for Q1 were 8.3% higher than the prior-year quarter's $0.12 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 66.2%, 90 basis points worse than the prior-year quarter. Operating margin was 11.3%, 140 basis points worse than the prior-year quarter. Net margin was 8.3%, 30 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $107.7 million. The average EPS estimate is $0.67.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 96 members out of 106 rating the stock outperform, and 10 members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Vascular Solutions a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vascular Solutions is outperform, with an average price target of $18.21.

Is Vascular Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.